Osteostatin improves the osteogenic activity of fibroblast growth factor-2 immobilized in Si-doped hydroxyapatite in osteoblastic cells. [electronic resource]
Producer: 20121001Description: 2770-7 p. digitalISSN:- 1878-7568
- Aged
- Aged, 80 and over
- Alkaline Phosphatase -- metabolism
- Animals
- Antibodies, Neutralizing -- pharmacology
- Biocompatible Materials -- pharmacology
- Calcification, Physiologic -- drug effects
- Cell Line
- Cell Proliferation -- drug effects
- Culture Media, Conditioned -- pharmacology
- Durapatite -- pharmacology
- Fibroblast Growth Factor 2 -- pharmacology
- Gene Expression Regulation -- drug effects
- Humans
- Immobilized Proteins -- pharmacology
- Mice
- Osteoblasts -- drug effects
- Osteogenesis -- drug effects
- Parathyroid Hormone-Related Protein -- pharmacology
- Peptide Fragments -- pharmacology
- Sus scrofa
- Vascular Endothelial Growth Factor A -- genetics
- Vascular Endothelial Growth Factor Receptor-1 -- genetics
- Vascular Endothelial Growth Factor Receptor-2 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.